This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Idorsia Pharmaceuticals Ltd. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: The Innovations of Lorenza Wyder Peters
Introduction
Lorenza Wyder Peters is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 2 patents to his name, Peters is recognized for his innovative work in receptor modulation.
Latest Patents
Peters' latest patents focus on N-substituted indole derivatives as PGE2 receptor modulators. The inventions relate to derivatives of a specific formula, which are described in detail in the patent documentation. These compounds are intended for use as pharmaceuticals, particularly in the modulation of prostaglandin 2 receptors EP2 and/or EP4. The patents also cover the preparation of these derivatives and their pharmaceutically acceptable salts.
Career Highlights
Lorenza Wyder Peters is currently associated with Idorsia Pharmaceuticals Ltd., where he continues to advance his research and development efforts. His work has been instrumental in exploring new therapeutic avenues in the pharmaceutical industry.
Collaborations
Peters collaborates with esteemed colleagues such as Heinz Fretz and Isabelle Lyothier, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Lorenza Wyder Peters exemplifies the spirit of innovation in the pharmaceutical field through his patents and collaborative efforts. His work on PGE2 receptor modulators showcases the potential for new treatments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile